Cargando…
Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
Atherosclerosis plaques caused by cerebrovascular and coronary artery disease have been the leading cause of death and morbidity worldwide. Precise assessment of the degree of atherosclerotic plaque is critical for predicting the risk of atherosclerosis plaques and monitoring postinterventional outc...
Autores principales: | Li, Xue, Wu, Menglin, Li, Jiang, Guo, Qi, Zhao, Yang, Zhang, Xuening |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606597/ https://www.ncbi.nlm.nih.gov/pubmed/36313319 http://dx.doi.org/10.3389/fphar.2022.906512 |
Ejemplares similares
-
Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022) -
Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
por: Hu, Ping Ping, et al.
Publicado: (2022) -
Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque
por: Mushenkova, Nataliya V., et al.
Publicado: (2020) -
Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis
por: Ma, Ying, et al.
Publicado: (2021) -
Editorial: Advances and Challenges in Nanomedicine
por: Hua, Susan, et al.
Publicado: (2018)